EV/EBITDA
-2.82
+0.16+5.37%
115 min ago
Summary
- As of March 13, 2025, MLYS EV/EBITDA is -2.82, with a rise of +0.16 (+5.37%) during the most recent trading day.
- Over the past year, MLYS EV/EBITDA has increased by +4.11 (+59.31%).
- MLYS EV/EBITDA is now -73.01% below its all-time high of -1.63.
Performance
MLYS EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
MLYS EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +5.4% | -5.5% | -4.6% |
| 1 m1 month | -32.4% | +32.6% | +25.5% |
| 3 m3 months | +6.6% | +6.7% | +8.3% |
| 6 m6 months | +25.4% | +6.7% | +13.7% |
| ytdytd | -8.5% | +8.7% | +7.1% |
| 1 y1 year | +59.3% | -7.5% | +2.5% |
| 5 y5 years | - | - | - |
MLYS EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -73.0% | -3.33 | +15.3% | |
| 3 m | 3-month | -1.63 | -73.0% | -3.41 | +17.3% |
| 6 m | 6-month | -1.63 | -73.0% | -3.97 | +29.0% |
| 1 y | 1-year | -1.63 | -73.0% | -7.71 | +63.4% |
| 3 y | 3-year | -1.63 | -73.0% | -22.06 | +87.2% |
| 5 y | 5-year | -1.63 | -73.0% | -22.06 | +87.2% |
| alltime | all time | -1.63 | -73.0% | -22.06 | +87.2% |
Mineralys Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -2.82(+8.5%) |
| Date | Value |
|---|---|
| 2024 | -2.60(-27.8%) |
| 2023 | -3.60 |
FAQ
- What is Mineralys Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Mineralys Therapeutics?
- What is MLYS EV/EBITDA year-to-date change?
- What is Mineralys Therapeutics EV/EBITDA year-on-year change?
What is Mineralys Therapeutics EV/EBITDA?
The current EV/EBITDA of MLYS is -2.82
What is the all time high EV/EBITDA for Mineralys Therapeutics?
Mineralys Therapeutics all-time high EV/EBITDA is -1.63
What is MLYS EV/EBITDA year-to-date change?
Mineralys Therapeutics EV/EBITDA has changed by -0.22 (-8.46%) since the beginning of the year
What is Mineralys Therapeutics EV/EBITDA year-on-year change?
Over the past year, MLYS EV/EBITDA has changed by +4.11 (+59.31%)